Novartis
Top 10 pharma execs leading sustainability efforts
June 09 by Leila HawkinsPharma IQ lists 10 pharma execs leading efforts to drive sustainability goals
Five ways pharma is reducing its carbon emissions
May 31 by Leila HawkinsPharma IQ looks at ways the pharma industry is aiming to become carbon neutral
Highlights from Pharma IQ Live: Pharmaceutical Manufacturing Automation 2022
May 24 by Leila HawkinsKey takeaways from Pharma IQ Live: Pharmaceutical Manufacturing Automation 2022
Keeping tabs on pharma: FDA fast tracks Novartis osteoarthritis drug and grants approval for Janssen’s long-acting schizophrenia drug
September 03 by Adam JeffsPharma IQ dives into the latest updates from the FDA for new drugs that have been developed by Novartis and Janssen
Keeping tabs on pharma: Novartis gene therapy drug brings hope to NHS patients and Covid-19 outbreak brings disruption to Yantian port
June 18 by Emily UwemedimoDisruptions at China’s Yantian port shows no signs of being resolved quickly
Unlocking the power of data to advance pharma businesses
February 10 by Pharma IQDiscover a data-driven approach from Merck to enhance pharma’s digital business economy
Keeping tabs on Covid-19: BioNTech buys GMP-certified facility to boost vaccine production and new specimen collection kit decreases Covid-19 testing turnaround times
September 18 by Emily UwemedimoBig names in pharma reinforce their commitment to fight the Covid-19 pandemic with new vaccine tests and production solutions
Pharma & Biotech News Highlights Q3 2016
October 18 by Pharma IQ NewsFollowing a quarter that featured reports stating that Novartis had dramatically redistributed its cell and gene therapy unit 1 and saw the public focus turn once again to drug price hikes, Pharma IQ...
The World’s Biggest Pharmaceutical Companies & The Industry Giants who Lead Them
April 30 by Pharmaceuticals & Biotechnology EditorIn this eBook, we take a look at the top 10 pharmaceutical companies ranked by sales as reported in the Forbes Global 2000 list, looking at the challenges they face and the leaders who will guide th...
GSK and Novartis Agree Multi-Billion Asset Swap
April 24 by Gerald ClarkePharma restructuring continues unabated and the latest deals to be announced are some of the biggest yet. Most of the major players in the market have undergone dramatic shifts in how they do busine...
Flurry of Big Pharma Deals ‘Makes Sense’
April 22 by Pharma IQ NewsNovartis and GlaxoSmithKline have agreed to exchange assets and combine their consumer healthcare units. Novartis has also agreed to sell its animal health division to Lilly for nearly $5.4bn. Ali...
Novartis' Jennifer Sheng on Solubility Modelling & the Future of Solubilisation
December 10 by Andrea CharlesPoor solubility is an obvious barrier to advancing potentially efficacious drug candidates. In this interview Jennifer Sheng, Fellow at Novartis, discusses the most efficient approaches for...